US Pharma MarketingEU probes Sanofi for alleged smear campaign against rival flu vaccine
The European Commission said it has started an investigation into whether Sanofi flouted competition rules while marketing its enhanced flu vaccine for over 60s, known as Efluelda. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR…
The European Commission said it has started an investigation into whether Sanofi flouted competition rules while marketing its enhanced flu vaccine for over 60s, known as Efluelda.
The French pharma company may have used “misleading ...
Source: Endpoints News